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Pediatric Gastroenterology, “Di Cristina” Hospital, Palermo, ItalyWe investigated how many patients with a diagnosis of
nonceliac wheat sensitivity (NCWS) still experienced wheat
sensitivity after a median follow-up time of 99 months. We
collected data from 200 participants from a previous study
of NCWS, performed between July and December 2016 in
Italy; 148 of these individuals were still on a strict wheat-
free diet. In total, 175 patients (88%) improved (had fewer
symptoms) after a diagnosis of NCWS; 145 of 148 patients
who adhered strictly to a gluten-free diet (98%) had
reduced symptoms, compared with 30 of 52 patients who
did not adhere to a gluten-free diet (58%) (P < .0001). Of
the 22 patients who repeated the double-blind, placebo-
controlled challenge, 20 reacted to wheat. We conclude
that NCWS is a persistent condition. Clinicaltrials.gov
registration number: NCT02823522.Keywords: Food Allergy; GFD; Outcome; IBS.
onceliac gluten/wheat sensitivity (NCG/WS)Abbreviations used in this paper: DBPC, double-blind, placebo controlled;
GAI, Global Assessment of Improvement; GFD, gluten-free diet; IBS,
irritable bowel syndrome; NCG/WS, nonceliac gluten/wheat sensitivity;
NCWS, nonceliac wheat sensitivity.
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related diseases.1,2 Monitoring the patient during the
elimination diet and the re-introduction of wheat by a
double-blind, placebo-controlled (DBPC) challenge has been
suggested as the ideal diagnostic method.3 Many aspects of
NCG/WS still remain unclear and it is unknown whether it is
a long-life condition.
In the year 2012 we published a retrospective study of
276 patients with a marked immunologic condition
(intraepithelial lymphocyte count >25/100 epithelial cells
in the duodenal mucosa), and irritable bowel syndrome
(IBS)-like symptoms, who had been diagnosed with
NCG/WS by DBPC challenge during a 10-year period
(2001–2011).4
The present prospective study aimed to investigate the
persistence of NCG/WS in that cohort, and 200 patients
(19 men, 181 women; mean age, 40 ± 13 y) were accepted
for inclusion 65–72 months (median, 99 mo) after NCG/WS
diagnosis (for details see the Supplementary Materials and
Methods section).
Continuing adherence to a wheat-free diet and the
severity of the IBS-like symptoms were evaluated via
structured questionnaires (Supplementary Materials and
Methods).Furthermore, 22 consenting patients still on a wheat-
free diet (21 women; mean age ± SD, 35.4 ± 9.3 y) were
randomized to undergo a repeat DBPC wheat challenge
(see the Supplementary Materials and Methods section for
more detail).
All authors had access to the study data and reviewed
and approved the ﬁnal manuscript.
Materials and Methods
See Supplementary Materials and Methods.
Results
Compliance With the Wheat-Free Diet
Figure 1A shows that 148 (74%) patients still were
following a wheat-free diet (score, 3 or 4). More speciﬁcally,
21 patients (10%) strictly avoided wheat, but consumed
other gluten-containing foods, including barley and rye
(score, 3), and 127 patients (64%) were on a strict gluten-
free diet (score, 4). The patient groups with scores of both
3 and 4 reported that involuntary consumption of wheat-
containing foods caused the recurrence of intestinal and
extra-intestinal symptoms listed in the Supplementary
Materials and Methods section (Supplementary Table 1).
Only 42 patients (21%) did not adhere to the wheat-free diet
at all (score, 0–1), and 10 others adhered to the diet but not
strictly (score, 2). Among these, 15 patients had resumed a
wheat-containing diet without any problems, 14 patients had
received a diagnosis other than nonceliac wheat sensitivity
(NCWS) and consequently were consuming wheat again, 11
patients conﬁrmed that wheat triggered symptoms but they
ate it by choice, and 12 patients ate wheat because they could
not afford gluten-free products but reported IBS-like symp-
toms after consuming it.
Figure 1. (A) Level of adherence to a wheat-free diet in
patients diagnosed with NCWS, after a 65- to 172-month
follow-up period. The percentage of the patients is shown.
Adherence was scored according to a modiﬁed version of
Biagi et al12 (see the Supplementary Materials and Methods
section), as follows: score of 0 indicates that they consume
wheat regularly or taste it so often that they cannot remember
when and how many times that has happened; score of 1
indicates that they consume wheat rarely, the patient con-
sumes wheat only occasionally; they can remember when
and how many times that has happened; score of 2 indicates
that they avoid wheat but when they eat out they do not
inform the person who is cooking for them about their disease
or do not check the labels on packaged food; score of 3 in-
dicates that they avoid wheat regularly, even at social events;
however, they eat packaged food even if it is not guaranteed
by the Celiac Association, and eat other nonwheat, gluten-
containing foods; and score of 4 indicates that they avoid
wheat and gluten regularly, even at social events, and eat
packaged food only if it is guaranteed by the Celiac Associ-
ation. (B) A well-being score was recorded for the study pa-
tients according to the IBS-GAI. The percentage of the
patients is shown. We asked patients the following,
“Compared with the way you felt before the NCWS diagnosis
and the consequent wheat-free diet, have your IBS symp-
toms been: worse (IBS-GAI score, A–C), unchanged (IBS-GAI
score, D), or improved (IBS-GAI score, E–G)?
EDITOR’S NOTES
BACKGROUND AND CONTEXT
Non-celiac wheat sensitivity (NCWS) has been recently
included among the gluten-related diseases, however,
many aspects of NCG/WS remain unclear and it is
unknown whether it is a long-life condition.
NEW FINDINGS
After a follow-up time of 8 years, 148 of the 200 NCWS
patients were still on a strict wheat-free diet. The
percentage of patients who had improved was
signiﬁcantly higher in those who still fully complied with
the diet. Double-Blind-Placebo-Controlled challenge
conﬁrmed NCWS in 90% of the patients.
LIMITATIONS
This Study included patients who had a marked
immunologic component that can suggest an allergic
condition. Thus, NCWS can be considered a persistent
condition only in the presence of similar patient
characteristics.
IMPACT
NCWS can be a persistent condition and, in these cases,
a long-term adherence to a wheat-free diet determines a
signiﬁcant improvement in the patients’ symptoms.
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Figure 1B shows the “well-being score” according to the
IBS Global Assessment of Improvement (GAI). In total, 175
patients (88%) improved after a NCG/WS diagnosis. The
frequency of patients who slightly, moderately or substan-
tially improved (IBS-GAI respondent) after a NCWS diag-
nosis was signiﬁcantly higher in the subjects who still
strictly adhered to the gluten-free diet (GFD) than in those
who did not: 145 of 148 patients (scores E–G, 98%) vs 30 of
52 patients (scores A–D, 58%) (chi-square for Mantel–
Haenszel, 36.7; P < .0001) (Figure 2).
Variables Associated With Following the GFD
Adherence to the diet was associated only with female
sex (P ¼ .03, Fisher’s exact test) and histology ﬁndings of
eosinophil inﬁltrate in the intestinal mucosa, evaluated at
diagnosis (P < .0001, Fisher’s exact test; odds ratio, 5.8; 2.7–
12.3). No difference in diet adherence was observed for HLA
status.
Results of the DBPC Wheat Rechallenge
The 22 patients randomized to the DBPC wheat rechal-
lenge study were all on a strict gluten-free diet and
asymptomatic before entering the study. Symptoms reap-
peared during the DBPC wheat challenge after a median
time of 2 days (range, 3 h to 8 days). Only 2 patients reacted
to the placebo. The score on the wheat-containing diet
was signiﬁcantly higher than on the placebo both at the end
of the ﬁrst and second weeks into the DBPC challenge
(P < .0001, Mann–Whitney). Including the 2 patients who
also reacted to the placebo, 20 of the 22 (91%) patients
were conﬁrmed to be suffering from NCG/WS.Discussion
Several studies have conﬁrmed an immunologic activa-
tion in NCG/WS,5–7 however, it is not known whether this is
a deﬁnitive condition.8,9
Our data show that approximately 74% of 200 patients
had remained on a strict wheat-free diet for a median time
of >8 years after a NCG/WS diagnosis, and they all reported
that involuntary wheat consumption regularly caused
symptoms. Only 42 patients had abandoned the wheat-free
Figure 2. Relationship be-
tween Biagi et al12 and
IBS-GAI score in NCWS
patients. The number and
percentage of the patients
are shown.
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REPORTSdiet, although 23 of these patients conﬁrmed they were sure
of their wheat sensitivity because they had symptoms after
consuming wheat. In total, NCWS persisted in 171 of 200
patients (85%).
Ninety percent of the patients who maintained a wheat-
free diet had a statistically signiﬁcant improvement in their
IBS symptoms. These results underline the importance of
correctly identifying NCWS patients because the elimination
diet deﬁnitively resolved their symptoms, a result that no
medical treatment achieves in IBS patients.
The real persistence of NCWS also was shown by the
results of the DBPC wheat challenge, repeated approxi-
mately 8 years after the ﬁrst diagnostic challenge in a small
group of patients.
Our ﬁndings must be considered with caution. We
studied a cohort of patients who had a marked immunologic
component, which can suggest an allergic condition.10 It
could be hypothesized that these patients were suffering
from a non–IgE-mediated food allergy, a hypothesis that
may be consistent with the confocal endoscopy images of
the duodenal mucosa during provocative tests in IBS pa-
tients.11 Furthermore, the study was underpowered to
determine if male sex was associated with adherence to the
GFD. Thus, NCWS can be considered a persistent condition
only in the presence of similar patient characteristics.
In conclusion, our study shows that NCWS can be a
persistent condition.
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Supplementary Materials and Methods
Patient Enrollment
Between July and December 2016, the patients included
in the previous retrospective study1 were contacted by
telephone, mail, and e-mail, and invited to return to the
respective clinics where they had been diagnosed initially
as NCG/WS patients: the Department of Internal Medicine
at the University Hospital of Palermo and the Department of
Internal Medicine of Sciacca Hospital. The 22 patients
included in the previous study who tested positive for anti-
endomysium antibodies in the culture medium of the
duodenal biopsies, even if the villi crypt ratio in the
duodenal mucosa was normal, were excluded from
the present study. Of the 254 remaining patients, 34 were
not found and 20 refused to return to the clinics. In all, 200
patients (19 men, 181 women; mean age, 40 ± 13 years)
previously diagnosed with NCG/WS by DBPC challenge
were re-evaluated. These patients had been diagnosed with
NCG/WS in our outpatient clinics in a period ranging
between 65 and 172 months (median, 99 mo) before the
present study.
Questionnaire to Verify Adherence to a
Wheat-Free or Gluten-Free Diet
A structured questionnaire was administered to eval-
uate how many patients were still on a wheat-free or
gluten-free diet. We used a simple score suggested by Biagi
et al2 based on 4 simple questions, modiﬁed to be applied to
a wheat-free diet. The score ranges from 0 to 4, in which a
score of 0 or 1 indicates that the patients are not on a
wheat-free diet anymore; a score of 2 indicates that they are
on a wheat-free diet but not strictly; a score of 3 indicates
that they are on a strict wheat-free diet, but not a GFD; and
a score of 4 indicates that they are on a strict GFD.
Questionnaires to Evaluate the Severity of
IBS and the Effect of the Wheat-Free Diet
The same researchers (A.C., P.M., A.D., and G.I.) who
initially evaluated the patients and reached the NCG/WS
diagnosis administered a modiﬁed version of the IBS-GAI
scale.3 According to the IBS-GAI, we asked patients:
“Compared with the way you felt before the NCG/WS
diagnosis, have your IBS symptoms been (A) substantially
worse, (B) moderately worse, (C) slightly worse, (D) no
change, (E) slightly improved, (F) moderately improved, or
(G) substantially improved.”
According to the IBS-GAI score, a respondent was
deﬁned as a patient whose symptoms were either slightly,
moderately, or substantially improved compared with the
period preceding the NCG/WS diagnosis.
We also evaluated the correlation between the level of
adherence to the wheat-free diet with the following vari-
ables, as evaluated in the retrospective study, at the time of
the NCG/WS diagnosis: age, sex, duration of the IBS symp-
toms, age at the NCG/WS diagnosis, presence of multiple
food hypersensitivity, presence of the DQ2 and/or DQ8 HLA
haplotypes, presence of intraepithelial lymphocyte inﬁltra-
tion in the duodenal mucosa, presence of eosinophil
inﬁltration in the duodenal or rectal mucosa, and associated
atopic diseases. The methods used and the deﬁnitions of the
earlier-described variables are described in the section on
the Deﬁnitions, Criteria, and Methods Adopted.
Double-Blind Challenge Method
The double-blind challenge method was performed with
the same method used in the retrospective study and
previously described.1 In brief, the DBPC challenge was
performed with capsules coded as A or B, containing 15 g of
wheat ﬂour or xylose, respectively. Capsules A or B were
given for 2 consecutive weeks and then after 1 week of
washout the patients received the other capsules for
another 2 weeks (cross-over design). During all phases of
the study, including the challenge period, the severity of
symptoms was recorded: the patients completed a 100-mm
visual analog scale, with 0 representing no symptoms,
which assessed overall symptoms and the speciﬁc symp-
toms each patient reported. The challenges were considered
positive when clinical reactions occurred (increase in VAS
score >30) for at least 2 consecutive days (onset of
abdominal discomfort or pain, associated with a change in
stool frequency and/or appearance), and if the same
symptoms that had been presented initially reappeared
after their disappearance on elimination diet.
Statistical Analysis
When data distribution was Gaussian, values were
expressed as means ± SD and differences between the 2
groups were calculated using the Student t test. For
parameters with non-Gaussian distribution, values were
expressed as range and median, and differences between
the 2 groups were calculated using the Mann–Whitney
U test. The Mantel–Haenszel test was used to compare the
response to the gluten-free diet (well-being score according
to IBS-GAI) in NCG/WS patients who still adhered to the
GFD or not. The chi-square test or the Fisher exact test was
used to test the frequencies. The SPSS software package
(version 16.0; Chicago, IL) was used for statistical analysis.
The study was approved by the Ethics Committee of the
University Hospital of Palermo.
All patients provided informed consent to participate.
Deﬁnitions, Criteria, and Methods Adopted
Multiple food sensitivity. All patients underwent at
least 4 weeks of elimination diet (exclusion of wheat, cow’s
milk and derivatives, egg, tomato, and chocolate). Then they
underwent a DBPC wheat challenge and all the patients
included in the present study reacted to the wheat chal-
lenge. All of these patients repeated the same elimination
diet and after 4 weeks underwent a DBPC cow’s milk
protein challenge. Those patients who also reacted to cow’s
milk protein challenge were classiﬁed as suffering from
multiple food sensitivities.
Presence of the DQ2 and/or DQ8 HLA
haplotypes. Patients were typed for HLA-DQ phenotypes
July 2017 Nonceliac Wheat Sensitivity 58.e1
by polymerase chain reaction using sequence-speciﬁc
primers, with a DR and DQ sequence-speciﬁc primers kit
(Unipath SpA, Milan, Italy), or a rapid method (DQ-CD
Typing Plus; BioDiaGene, Palermo, Italy).
Presence of intraepithelial lymphocyte inﬁltration
in the duodenal mucosa. The number of intraepithelial
lymphocytes per 100 villous epithelial cells was assessed by
immunohistochemical staining: CD3þ intraepithelial lym-
phocytes were stained with monoclonal antibody Leu-4. The
upper limit of the reference interval in our laboratory was 25
intraepithelial lymphocytes per 100 epithelial cells. Conse-
quently, duodenal histology lesions were classiﬁed according
to Corazza and Villanacci: normal mucosa (villi to crypt
ratio >3 and CD3þ intraepithelial intestinal lymphocytes
<25/100 enterocytes) or grade A (villi to crypt ratio >3 and
CD3þ intraepithelial intestinal lymphocytes >25/100
enterocytes).4
Presence of eosinophil inﬁltration in the
duodenal or in the rectal mucosa. In the duodenum,
the number of lamina propria eosinophils per high-power
ﬁeld (40) was assessed in the mucosa; the upper limit of
the reference interval in our laboratory, at the time of the
retrospective study,1 was 60 lamina propria eosinophils per
10 high-power ﬁelds. In the rectum, eosinophils were
Supplementary References
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counted at a high-power ﬁeld (40) in cross-sections of 50
crypts randomly selected from each slide and these cell
numbers were expressed per 100 deep-crypt epithelial cells.
The eosinophil count in the lamina propria was expressed as
a percentage of eosinophils per 1000 lamina propria cells
per section (5 sections per biopsy were examined). On the
basis of the mean values þ2 SD observed in the colon biopsy
specimens of the control subjects, the upper limit of the
reference interval in our laboratory at the time of the
retrospective study was lamina propria eosinophils less
than 9.
Associated atopic diseases. Atopic diseases were
rhinitis, conjunctivitis, bronchial asthma, and atopic
dermatitis. They were diagnosed according to standard
criteria.
58.e2 Carroccio et al Gastroenterology Vol. 153, No. 1
Supplementary Table 1.Extraintestinal Symptoms That
Disappeared on a Wheat-Free Diet
and Recurred After Occasional and
Involuntary Consumption of Wheat-
Containing Food, Reported by the
148 NCWS Patients Who Still Were
Following a Strict Wheat-Free Diet
Symptom Number of cases
Lack of well-being 135 (91%)
Tiredness 102 (69%)
Foggy mind 68 (46%)
Menstrual alterations 54 (36%)
Anemia 46 (31%)
Weight increase 45 (30%)
Joint/muscle pain 35 (24%)
Headache 31 (21%)
Weight loss 30 (20%)
Anxiety 18 (12%)
Skin rash 16 (11%)
Recurrent cystitis 12 (8%)
Depression 10 (7%)
July 2017 Nonceliac Wheat Sensitivity 58.e3
